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Abstract
The influence of a radio-frequency electric field on glioma brain cancer develop-
ment is considered. Specifically, the effectiveness of this medical technology
against invasive cells with a high motility, when switching between migrat-
ing and proliferating phenotypes takes place, is addressed. It is shown that
glioma development under the external field treatment can be modelled in the
framework of the continuous time random walk, where the segregation of pro-
liferating from not proliferating cells by the external electric field is naturally
accounted for. The constructed reaction-transport equation is based on the fact
that cytokinesis affects the cell dynamics strongly, and the cell kinetics is non-
Markovian, which is reflected in both the transport and reaction properties of
cells. As a result of the interplay between cell proliferation and cell degradation,
migrating cancer cells spread freely without being influenced by the details of
the degradation of the proliferating cells, which leads to a decrease in the effec-
tiveness of the treatment.
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1. Introduction
A new therapeutic method suggested in [1, 2, 3] for non-invasive treatment of
glioma brain cancer by a radio-frequency electric field also opens new directions
of understanding of glioma development. A specific question that emerges is
the effectiveness of this new medical technology against invasive cells with high
motility, when switching between migrating and proliferating phenotypes takes
place. As is well known, one of the main features of malignant brain cancer is
the ability of tumor cells originating in the glioma to invade normal tissue at a
distance from the multi-cell tumor core. This abnormal motility constitutes the
metastasis feature of brain cancer, causing treatment failure [4]. This problem
relates to modelling of the dynamics of cancer glial cells in heterogeneous media
(as brain cancer is) in the presence of a radio-frequency electric field, which
acts as a tumor treating field (TTField) [1, 2, 3]. As reported, this transcranial
treatment by a low-intensity (1-3 V/cm), intermediate-frequency (100-200 kHz)
alternating electric field, produced by electrode arrays applied to the scalp,
destroys cancer cells that are undergoing division, while normal tissue cells are
relatively unaffected. An important result of this new treatment technology is
that the survival period is increased twofold.
Glioma is one of the most recalcitrant brain diseases, with a standard treat-
ment survival period of 7-12 months [3, 5]. One of the main mechanisms of
this devastating manifestation is the migration-proliferation dichotomy of can-
cer cells. This phenomenon was first observed in clinical investigations [6, 7],
where it was shown that cancer cells in the outer invasive zone of glioma pos-
sess the high motility property, while the proliferation rate of these migratory
cells is essentially lower than those in the tumor core. This anti-correlation be-
tween proliferation and migration of cancer cells, also known as the Go or Grow
hypothesis (see discussions in [8, 9]), suggests that cell division and cell migra-
tion are temporally exclusive phenotypes [6]. The phenomenon that tumor cells
defer proliferation for cell migration was also experimentally demonstrated in
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[10, 11, 12]1. The switching process between these two phenotypes is still not
well understood. Moreover, it should be mentioned that conflicting data appear
in the literature concerning the Go or Grow hypothesis; details of discussions
on this can be found in [9, 8].
Extensive theoretical modelling followed these findings, and much effort is
being invested in developing relevant models with relevant switching mecha-
nisms of the glioma cells to understand this dichotomy, when the high motility
suppresses cell proliferation in the outer invasive region, while the immobile
cancer cells have a high proliferation rate like the cells in the cancer core. There
are different approaches that have resulted in several phenomenological mod-
els, which have supplied also experimental in vitro confirmation data [14, 15].
Comprehensive discussions of these models appear in [14, 16, 17, 18, 19].
The main subject of the paper is the fractional kinetics of the new thera-
peutic technology [1, 2, 3], where the TTField acts against invasive proliferating
cancer cells. The TTField segregates proliferating cells (either transporting or
not) from transporting cells out of cytokinesis. As stated in Ref. [8], on the in-
dividual cell level, the processes of migration and proliferation are separated in
time. The TTField “fills” this dichotomy of a single cell. These facts are impor-
tant for a continuous time random walk (CTRW) description, since it is based
on the dynamics of a single particle (e.g., see review [20]). Therefore, we follow
the CTRW consideration presented in [21], where a mechanism for entrapping
transporting cells by fission was suggested, and the migration-proliferation di-
chotomy appears naturally. Therefore, the efficiency of the TTField action can
be evaluated in the framework of the fractional kinetics of glioma development
under the TTField treatment. The first study of this kinetics in the frame-
work of a fractional comb model [22] showed that the TTField efficiency is
restricted by its space dispersion. In particular, it depends on the fractal mass
dimension of the cancer cells. In the present research, we propose a general,
1This kind of migration-proliferation dichotomy was also found at metastatic behavior of
breast cancer [13].
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probabilistic consideration of cancer cell kinetics and obtain a solution for an
arbitrary distribution of proliferating cells, which can change in time and space.
In the framework of the constructed model, we show that the glioma develop-
ment corresponds to the compensated cancer development, when the TTField
compensates cell proliferation, and we consider this solution as the maximum
therapeutic effect of glioma treatment due to the TTField.
2. Time multi-scaling of the CTRW modelling of cell transport
2.1. Fission and motility times
A simplified scheme of the migration-proliferation dichotomy of cancer cells
can be considered by virtue of two time scales of tumor development [21]. The
first corresponds to the biological process of cell fission with random duration
Tf . The second process is cell transport with random duration Tt. During the
time scale Tf , the cells interact strongly with the environment, and the motility
of the cells is vanishingly small. During the second time Tt, interaction between
the cells is weak and the motility of the cells leads to cell invasion, which is
a very complex process controlled by matrix adhesion [4, 23, 24]. It involves
several steps, including receptor-mediated adhesion of cells to the extracellular
matrix (ECM), matrix degradation by tumor-secreted proteases (proteolysis),
detachment from ECM adhesion sites, and active invasion into the intercellular
space created by protease degradation. It is convenient to introduce a “jump”
length, Xt, of these detachments as the distance that a cell travels during the
time Tt. Hence, the cells form an initial packet of free spreading particles,
and the contribution of cell dissemination to the tumor development process
consists of the following time sequences: Tf (1)Tt(2)Tf (3). There are different
realizations of this chain of times, due to different durations of Tf (i) and Tt(i),
where i = 1, 2, . . .. Therefore, one concludes that transport is characterized by
random values T (i), which are waiting (or self–entrapping) times between any
two successive jumps of random length X(i). This phenomenon is known as a
continuous time random walk (CTRW) [25]. It arises as a result of a sequence
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of independent identically distributed random waiting times T (i), each having
the same pdf ψ(t), t > 0 with a mean characteristic time T , and a sequence of
independent identically distributed random jumps, x = X(i), each having the
same pdf p(x) with a jump length variance σ2, equal to the square averaged
intercellular/cellullar space σ ∼ 10−3cm. It is worth mentioning that a cell
“carries” its own trap, by which it is set apart from the transport process. This
process of self–entrapping differs from the standard CTRW, where traps are
external with respect to the transporting particles. The probability to “escape
from i-th trap” of fission is locally determined by the Poisson distribution e−t/τi
with different time scales, or even random scales.
2.2. Example of power law: a toy model
This absence of a unique time scale leads to the power law distribution of
fission times. For example, one can suppose that self-entrapping for different
generations of cells has different mean characteristic time scales. We consider
that the j-th generation of self-entrapping is the Poisson process
wj(t) = τ
−1
j exp (−t/τj)
with the characteristic time scale τj = τ
j , where τ1 = τ is now an average
cell division time for the first generation. Therefore, following [26, 27] and
repeating exactly the analysis of Ref. [27], we obtain, by taking into account
events occurring on all time scales, the distribution
ψ(t) =
1− b
b
∞∑
j=1
bjτ−j exp
(−t/τ j) ,
where b < 1 is a normalization constant. Therefore, the last expression is a
normalized sum and
ψ(t/τ) = τψ(t)/b − (1− b) exp (−t/τ) /b .
Using conditions t ≫ τ > 1/b, one obtains that at longer times ψ(t/τ) =
τψ(t)/b. The last expression is equivalent to
ψ(t) ∼ 1/t1+α , (1)
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where α = ln(b)/ ln(1/τ).
2.3. Power law distribution of fission times
As shown in the above example, one obtains that the pdf accounts for all
exit events from the proliferation process occurring on all time scales, and has
the power law asymptotic solution (1), where 0 < α < 1 and τ is a characteristic
time. Taking into account the normalization condition, one obtains
ψ(t) =
ατα
(τ + t)1+α
(2)
In this case, the averaged time is infinite. A clear explanation of Eq. (2) can be
the following quotation from Ref. [28]: “A process with the long tailed pausing
time distribution would suffer a very sporadic behavior – long intermittencies
may exist, followed by bursts of events. The more probable pauses between
events would be short but occasionally very long pauses would exist. Given a
long pause, there is still a smaller but finite probability that an even longer one
will occur. It is on this basis that one would not be able to measure a mean
pausing time by examining data.”
Following statistical arguments, one should bear in mind that the absence
of a scale (or existence of a random fission scale) follows from the variety of
fluctuations of the cell environment with which cancer cells interact [29]. As
stated in [8], the competition of proliferation and migration for the finite free
energy resources supports the mutual exclusiveness of these cellular processes.
Therefore, for the fixed cell energy, there is a degeneracy property of many cell
states that leads to the cell state entropy2 S. As a result of this interaction
with the environment and the energy competition, as well as of the environ-
mental fluctuations, the escape probability from the “fission traps” is described
by Boltzmann’s distribution exp(S). This value is proportional to the inverse
waiting time t−1 ∼ exp(S) [31]. Obviously, S depends on a variety of external
2Note that the entropy is negative. For the entropy role in carcinogenesis and tumor growth
see paper by Gatenby and Frieden [30].
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(environmental) characteristics and can be considered as a random value with
the Poisson distribution (for the local time and space) P (S) = 1〈S〉 exp (S/〈S〉),
where a normalization constant 〈S〉 is the absolute value of the mean entropy.
The probability to find the waiting time in the interval (t, t + dt) is equal to
the probability to find the entropy (as a trapping potential) in the interval
(S, S + d(−S)), namely, ψ(t)dt = P (S)d(−S). Taking into account these prob-
abilistic arguments, one obtains ψ(t) ∼ αt1+α . This leads to the normalized
distribution of Eq. (2), where the transport exponent α, as a rate of the escape,
is determined as the inverse mean entropy
α =
1
〈S〉 . (3)
3. Kinetic equation of cell CTRW
Since the pdfs of waiting times ψ(t) and jump length p(r) are specified
in Sec. 2, we can construct a kinetic equation of cells, following the CTRW
approach [25] and paraphrasing it from [20, 31]. First, we consider a process of
jumps. Let Pj(r) be the pdf of being at r after j jumps. As described in Sec. 2,
the cell jumps are independent and obey the Markov property
Pj+1(x) =
∫
Pj(r
′)p(r− r′)d3r′ , (4)
where P0(r) is the initial condition.
Now, let us consider the pdf ψ(t) taking into account the dynamics of the
jumps. As mentioned in Sec. 2, waiting times for different jumps are statistically
independent. Therefore, indexing the waiting time pdf by the jump number,
we define that ψj(t) is the probability density that the jth jump occurs at time
t (see e.g., [31], p.42). Because of the reasonable assumption that jumps are
independent transitions, we also introduce the Markov property for ψj(t), which
reads
ψj+1(t) =
∫ ∞
0
ψj(t
′)ψ(t− t′)dt′ , (5)
where ψ1(t) ≡ ψ(t). Now, we introduce the pdf P (r, t) =
∑
j Pj(r)ψj(t) of
arriving at coordinate r at time t. From Eqs. (4) and (5), we introduce the
7
equation [20]
P (r, t) =
∫ ∞
−∞
p(r− r′)
∫ ∞
0
ψ(t− t′)P (r′, t′)d3r′dt′ + P0(r)δ(t) , (6)
which relates the pdf P (r, t) of just having arrived at position r at time t to
the pdf P (r′, t′) of just arriving at r′ at time t′. The last term in Eq. (6) is the
initial condition. Thus, the pdf n(r, t) of being at position r at time t is given
by arrival at r at time t′ and not moving after this event, namely
n(r, t) =
∫ t
0
P (r, t′)Ψ(t− t′)dt′ , (7)
where Ψ(t) = 1− ∫ t0 ψ(t′)dt′ denotes the probability of no jump during the time
interval (0, t). Performing the Fourier transform p¯(k) = Fˆp(x) and the Laplace
transform ψ˜(s) = Lˆψ(t), we obtain the Montroll-Weiss equation [25]
nˆ(k, s) = FˆLˆn = 1− ψ˜(s)
s
· nˆ0(k)
1− p¯(k)ψ˜(s) . (8)
Eq. (8) can be simplified for the long time s ≪ 1 and the large scale k ≪ 1
asymtotics, which corresponds to the diffusion limit (k, s) → (0, 0). For the
intermediate asymptotic times, restricted from above, t < Tmax, we consider
the large scale limit k ≪ 1 only. Here k = |k|. Taking into account the Fourier
p¯(k) image in Eq. (8), where
p(r) =
1√
4πσ2x
e
− x
2
4σ2x
1√
4πσ2y
e
− y
2
4σ2y
1√
4πσ2z
e
− z
2
4σ2z ,
one obtains
p¯(k) ≈ 1− σ
2
6
(k2x + k
2
y + k
2
z) . (9)
Here, the factor 16 is responsible for the equal probability to jump in either
direction. Substituting Eq. (9) in the Montroll-Weiss equation (8), one obtains
a kinetic equation in the Fourier-Laplace space. Performing the Fourier and
the Laplace inversion, one obtains the kinetic equation of cancer cells without
proliferation.
∂tn(r, t) =
σ2
6
∆
∫ t
0
K(t− t′)n(r, t′)dt′ . (10)
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Here, ∆ = ∂2x + ∂
2
y + ∂
2
z and the kinetic kernel of the transition probability
K(t) sψ˜(s)
1−ψ˜(s)
is determined from Eq. (8). In the next section, we consider a
general scheme of cancer cells transport provided with the antimitotic treatment
of proliferating cancer cells.
4. CTRW analysis with antimitotic treatment
We are concerned with the problem of the glial cancer cell spreading in the
outer invasive region as a growing tumor spheroid, where the density of cells is
n(r, t) and r = (x, y, z). Following a standard CTRW scheme for the description
of a non-Markovian transport, suggested in Secs. 2 and 3, we introduce a power
law waiting time probability distribution function (waiting time pdf) ψ(t) ∼
τ/t1+α between any two successive cell moves/jumps, where 0 < α < 1 and τ is
a characteristic time scale; for example, it can be the average time of the cell’s
division. This function has a general impact on both the transition probability
kernel and the proliferation kernel, which govern the total density of cancer cells
n(r, t) in the framework of the master equation
∂tn(r, t) =
σ2
6
∆
∫ t
0
K(t− t′)n(r, t′)dt′ +
−
∫ ∞
−∞
d3r′
∫ t
0
C(r− r′, t− t′)n(r′, t′)dt′ . (11)
The kinetic part of the equation is inferred in the previous section, see Eq. (10).
Here, the kinetic kernel of the transition probability K(t) reflects non-Markovian
cell transport and it relates to the waiting time pdf ψ(t) in the Laplace space
of the Montroll-Weiss equation [25] 3
K˜(s) = Lˆ[K(t)] = sψ˜(s)
1− ψ˜(s) , ψ˜(s) = Lˆ[ψ(t)] . (12)
Like any chronic antimitotic treatment, the proliferation-treating kernel, or
the TTField kernel C(r, t) describes an effect of the TTField action on the pro-
3In the Markov case, when ψ(t) = 1
τ
e−t/τ and K(t − t′) = 1
τ
δ(t − t′), the kinetic part
reduces to the standard Fokker-Planck equation ∂tn(r, t) = K∆n(r, t), where K =
σ2
6τ
.
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liferating cells4. In the general case, it is a random in space and time operator.
Another important property of the cell proliferation in the outer invasive region
is that this process takes place in some fraction of the invasive volume with some
fractal dimension Dfr. Here, the TTField action will be considered as an aver-
aged result of the competition between proliferation and degradation (due to the
TTField) of cells with the maximum therapeutic effect. In this case, the disper-
sion of the TTField kernel is described in the Fourier space C(k, t) = Fˆ [C(r, t)].
We take this dependence in the multiplicative form, where the TTField kernel
is proportional to the dispersion of the proliferation cell density C0(k) and its
probability Ψ(t) to stay in the proliferation phenotype until time t:
C(k, t) = C0(k)Ψ(t) = C0(k)
∫ ∞
t
ψ(t′)dt′ , (13)
and C˜(k, s) = Lˆ[C(t)] = C0(k)(1 − ψ˜(s))/s. Here, the dispersion C0(k) >
0 is also a compensation rate between a cell’s degradation and proliferation,
which depends on the density of proliferating cancer cells. At this point, we
do not specify explicitly the details of this dispersion. Note only that in a
dispersionless case, C0 = const, and integration over the space in Eq. (11)
disappears. Equation (11) in the Fourier-Laplace space reads
snˆ = −σ
2
6
k2K˜(s)nˆ− C0(k)1 − ψ˜(s)
s
nˆ+ n¯0(k) , (14)
where nˆ ≡ nˆ(k, s) = FˆLˆ[n(r, t)] is the Fourier-Laplace image of the pdf and
k2 = |k|2. Here, n¯0(k) = Fˆ [n(r, t = 0)] is the Fourier image of the initial
conditions. For simplicity, we take it in the form of a constant value n0. In
this case, the pdf n(r, t) coincides with Green’s function. Therefore, the cell
4 Contrary to the drug anti-mitotic action, the modality of the TTField action is physical
and related to dielectrophoresis (see, e.g., [32]), when the non-uniformity of the TTField
exerts a force, focusing at the narrow cytoplasmatic bridge between two daughter cells at
fission. This leads to disruption of the cytokinesis stage of the cell proliferation; eventually,
the cells are destroyed without the quiescent cells of normal tissues being affected [1, 2, 3].
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dynamics is described by the Fourier and the Laplace inversions
n(r, t) = Fˆ−1Lˆ−1
[
n¯0
s+ σ
2
6 K˜(s)k2 + C0 1−ψ˜(s)s
]
. (15)
Here and in the following, we use C0 ≡ C0(k). In the Fourier space, solution (15)
can be expressed by the Mittag-Leffler function [33]. For the non-Markovian dy-
namics, the Laplace image of the waiting time pdf is ψ˜(s) = 11+(τs)α . Therefore,
the transition probability kernel (12) is K˜(s) = s1−α/τα, and the TTField term
is
C0
1− ψ˜(s)
s
=
C0τ
αsα−1
1 + (τs)α
≈ Cαsα−1 , (16)
where Cα = C0τ
α. We use τs ≪ 1, which corresponds to the consideration of
the cell dynamics at the time scale t≫ τ . Substituting these expressions in Eq.
(15), one expands the latter over the TTField term, defined in Eq. (16). This
yields
n(r, t) = n0Fˆ−1Lˆ−1

 ∞∑
l=0
(
− Cα
)l(
sα−1
)2l+1
(
sα +Kαk2
)l+1

 . (17)
Here, Kα =
σ2
6τα is a generalized diffusion coefficient.
5. The TTField kernel
Equation (17) can be presented in the form of the convolution between the
first term and the rest of the expansion. The first term of the expansion cor-
responds to the compensated cancer solution, when C0 = 0. As presented in
the previous section, the kernel C(k, t) in Eq. (13) results from the competi-
tion between proliferation and the antimitotic TTField action. Therefore, when
C0 = 0, the TTField compensates the proliferation of cancer cells. We call
this cancer development by “compensated cancer development”. Evidently, this
expression makes sense only for the cancer development in the presence of the
TTField, when C0 = 0, and only the first term remains in expansion (17). In
the Fourier space, this solution can be expressed by the Mittag-Leffler function.
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One obtains from Eq. (17)
nc(r, t) = Fˆ−1Lˆ−1
[
n0s
α−1
sα +Kαk2
]
, (18)
where the inverse Laplace transform is nothing but the definition of the Mittag-
Leffler function [33]
Eα
(
−Kαk2tα
)
=
∫ i∞
−i∞
estsα−1ds
sα +Kαk2
.
Note that the pdf nc(r, t) is the radial function, where r = |r|. Therefore, the
cancer development with proliferation compensated by the TTField is expressed
by the Fourier image of the Mittag-Leffler function
nc(r, t) = n0Fˆ−1
[
Eα
(
−Kαk2tα
)]
. (19)
One obtains from Eqs. (17), (18) and (19)
n(r, t) = nc(r, t) + n0Fˆ−1
[
Eα
(
−Kαk2tα
)
⋆R(kt) ,
]
(20)
where the Fourier inversion is the convolution integral with the TTField kernel
R(k, t) = R(k, t) = Lˆ−1

 ∞∑
l=1
(
− Cαs2α−2
)l
(
sα +Kαk2
)l

 . (21)
Symbol ⋆ in Eq. (20) denotes the time convolution integral.
Now, we estimate R(k, t). To this end, the denominator of the expansion
should be simplified in the limit sα ≫ Kαk2, which is valid in the outer invasive
zone. Performing this simplification, one obtains
 1(
sα +Kαk2
)l

 ≈ 1
sαl
[1− lKαk2/sα] . (22)
The Laplace inversion determines a generalization of the Mittag-Leffler function
[33] Eα,β(z) =
∑∞
l=0
zl
Γ(αl+β) , where Γ(αl+ β) (see Eq. (A. 9) in Appendix A);
one obtains
R(k, t) = −Cαt1−αE2−α,2−α
(
− Cαt2−α
)
+
+Kαk
2Cαt
∑∞
l=0
(l+1)(−1)lClαt
(2−α)l
Γ[(2−α)l+2] ≡ R1 +R2 . (23)
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Let us first treat the first term in Eq. (23). The argument of the Mittag-Leffler
functions is large, which yields the power-law behavior [20, 33]
Eα,β(z) ∼ −1
Γ(β − α)z . (24)
In this case, the TTField kernel needs to be treated in the framework of the
generalized functions (distributions) [34], which yields R1 = δ(t) for the kernel
in the convolution integral. This contribution to the distribution function in the
Fourier space is the inversion of the Mittag-Leffler function, which compensates
nc(r, t) exactly:
nc(r, t)− n0Fˆ−1
[
Eα
(
−Kαk2tα
)]
= 0 . (25)
Therefore, the solution in Eq. (20) is determined by the convolution with
the second term R2 of the TTField kernel in Eq. (23). To obtain the analytical
expression, some simplification of the gamma function should be performed.
This reads
l + 1
Γ[(2 − α)l + 2] =
l + 1
[(2 − α)l + 2]Γ[(2− α)l + 1] ≈
1
2Γ[(2− α)l + 1] . (26)
Again, we arrive at the two-parameter Mittag-Leffler function, whose asymp-
totic behavior (24) yields the kernel R2 = αKαk22Γ(α) tα−1. Therefore, one obtains
the fractional integration of the Mittag-Leffler function with the TTF kernel
n(r, t) =
n0αKα
2
Fˆ−1
[
k2
Γ(α)
∫ t
0
(t− t′)α−1Eα
(
−Kαk2t′α
)
dt′
]
. (27)
Note that n(r, t) is the radial function. The integration over the time is well
defined and yields (see e.g., [35] [Eq. (1.100)])
n(r, t) =
n0αKα
2
Fˆ−1
[
tαk2Eα,1+α
(
−Kαk2tα
)]
. (28)
In the outer invasive zone for the initial time scenario, when Kαk
2tα < 1 is
valid, the Mittag-Leffler function constitutes the stretched exponential behavior
[20, 33]
Eα,1+α
(
−Kαk2tα
)
∼ exp[−λKαk2tα] ,
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where λ = Γ(1+α). Note also that we work with the three-dimensional Fourier
transform. Therefore, since k2 = k2x+k
2
y+k
2
z , differentiating over λ reduces the
problem to the simple Fourier inversion of the Gaussian packets, which yields
n(r, t) = − ∂
∂λ
n0α
2
√
(4πλKαtα)3
exp
[
− r
2
4λKαtα
]
∝ r2(Kαt)− 3α2 exp
(
− r
2
Kαtα
)
. (29)
This solution (29) exhibits the result of the TTField action on the glioma de-
velopment that leads to subdiffusion, or the stretched exponential restriction of
the cancer cells spreading. An important fact here is that expression (29) is in-
dependent of C0 = C0(k) and, correspondingly, is independent of any dispersive
properties of the tissues interacting with the TTField.
As observed, the TTField cannot stop the cancer spreading as the averaged
radius of the outer invasive zone increases subdiffusively 〈r2(t)〉 ∼ tα. An exam-
ple of compensated cancer invasion with time is shown in Fig. 1. This weakening
of the TTField action is due to the migration-proliferation dichotomy, and is
reflected in the convolution treatment term with the power-law time delay ker-
nel C(t) = C0(k)Ψ(t) in Eq. (11). The final result in Eq. (29) is independent
of the treatment rate as well.
6. Untreated cancer development
The TTField action, as any other antimitotic treatment, is important and
leads to an increase in the survival period as a result of the essential decrease in
the cancer spread rate. To understand this phenomenon, one needs to compare
the spread of cancer cells with and without the TTFields. For example, let
us consider the overall velocity of the constant concentration front propagation
in the case of treated and untreated cancer. It follows from Eq. (29) that
the front of constant concentration corresponds, approximately, to the solution
r2 ∼ α2Kαtα ln t. Therefore, for C0 = 0, the spread rate of the treated cancer
decreases with time v0 = r˙ ∼ Kαtα2−1 and vanishes at the asymptotics t→∞.
The situation changes dramatically for untreated cancer. In the present analysis,
14
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Figure 1: Increasing concentration of cancer cells with time for the dimensionless radius r and
time, according to Eq. (29). Different plots correspond to different times: from bottom to
top t = 10, 25, 50, 75. Here, Kα = 1 and α = 1/3. In the vicinity of r = 6, the condition of
the outer invasive zone Kαtα/r2 ≪ 1 is fulfilled.
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it corresponds to C0 < 0, where in the absence of the TTField |C0| is now the
rate of proliferation of cancer cells. Cell proliferation contributes strongly to the
transport, since the density of cancer cells n(r, t) increases with time. It is well
known that this process leads to the nonzero velocity of the front propagation
[36, 37, 19], which has the form vC ∼
√
C0Kα. Therefore, the TTField leads to
the failure of the asymptotic front propagation of the cancer spread, while the
front of untreated cancer spreads with a constant velocity.
Another important property is the mean squared displacements (MSD) 〈r2(t)〉,
which can be calculated for both treated and untreated cancers. There are var-
ious scenarios of the cancer spread and some approaches have been presented
in [14, 16, 17, 18, 19]. Here, it is instructive to consider the cancer spread in
the presence of the migration-proliferation dichotomy as a renewal process (see
e.g. [38, 39]), following [19]. The switching between migrating and proliferating
phenotypes for untreated cancer leads to the superdiffusive/sub-ballistic spread
of cancer cells, when the transport exponent is larger than 1.
From the compensated cancer solution (29), one obtains that the MSD for
the treated cancer reads
〈r2(t)〉 ∼ Kαtα , (30)
which corresponds to subdiffusion. For untreated cancers, a reversible process of
switching between migration and proliferation phenotypes leads to the increase
in the cancer cell population. Therefore, to apply the renewal theory with the
constant cell population, we consider the dynamics of cells with the migration-
proliferation switching that are simultaneously moving together with the front
with the constant velocity vC . This yields the following scheme. The random
cell transport is considered for the constant number of cancer cells, while pro-
liferation contributes to advection with the constant velocity of the cancer cells
vC along the radial direction.
Now we take into account the process of migration-proliferation switching.
The residence time pdf for the cell proliferation, described by Eqs. (1) and (2),
is ψ(t) ∼ (τ/t)1+α with the infinite averaged residence time. Contrary to the
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proliferation time, the averaged transport time 〈t〉 = t¯ is finite. During this
time, cancer cells move the distance r(t¯) = vc t¯. To find the MSD 〈r2(t)〉 for the
asymptotically large time, we consider that the displacement of a cell at time t
is proportional to the number of migration-proliferation switchings N(t), such
that r(t) ∼ vC t¯N(t). Therefore, one obtains for the MSD 〈r2(t)〉 ≥ 〈r(t)〉2 ∼
[vC t¯]
2〈N(t)〉2.
Note that the number of cells is constant, and therefore, the distribution
function n(r, t) of cancer cells to be at the position r(t) at time t can be consid-
ered a function of the number of switchings n(r, t) ≡ p(N , t) = Pr[N(t) = N ].
Using a well known result from the renewal theory (see e.g. [38, 39]), one obtains
that the Laplace transform of p(N , t) is determined by ψ˜(s)
p˜(N , s) = ψ˜
N [1− ψ˜]
s
. (31)
One obtains the second moment 〈N2(t)〉 = ∑∞N=0N 2p(N , t), which reads in
the Laplace space
〈N˜2(s)〉 =
∞∑
N=0
N 2p˜(N , s) = 1− ψ˜
s
∞∑
N=0
N 2ψ˜N . (32)
Taking into account that for the large time asymptotic ψ˜(s) ≈ 1 − (sτ)α, one
obtains after the Laplace inversion that 〈N2(t)〉 ∼ (t/τ)2α/Γ(1 + 2α). Finally,
one obtains that the MSD reads
〈r2(t)〉 ∼ [vct¯]
2
Γ(1 + 2α)
(
t
τ
)2α
. (33)
As follows from Eqs. (30) and (33), the main benefit of any antimitotic treat-
ment, including the TTField, is decreasing the transport exponent of the cancer
spread twofold. Moreover, the changes can be more dramatic, when 12 < α < 1.
In this case the difference between treated and untreated cancer corresponds to
the difference between a subdiffusive cancer spread and a superdiffusive one.
7. Conclusion
Understanding of glioma cancer kinetics in the presence of the tumor treating
field (TTField) can be important for the further development of the TTField’s
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efficiency for medical treatment. It should be stressed that the TTField tech-
nology is already an officially accepted method for cancer treatment5. We have
shown that glioma development under the TTField treatment can be modelled
in the framework of the continuous time random walk, where the TTField seg-
regation of proliferating from not proliferating cells is naturally accounted. The
constructed reaction-transport equation (11) is based on the fact that the cytoki-
nesis affects the cell dynamics strongly, and the cell kinetics is non-Markovian,
which is reflected in both the transport and reaction terms of Eq. (11). As was
stated in Ref. [8] “As a matter of fact, in one single cell, cytokinesis and migra-
tion are separated temporally; but on the level of a cell population - and this
is the case of tumors - cell migration and proliferation occurs simultaneously.”
Obviously, for the CTRW consideration, which accounts for the dynamics of the
entire population at the individual particle level, the dynamics of one single cell
with the migration-proliferation dichotomy is the most important.
The TTField technology, eventually, fails to stop glioma cancer develop-
ment. This conclusion also correlates with the recent empirical (clinical) data,
observed in [40], where the effect of the field strength on glioblastoma multi-
forme response was studied in patients treated with the TTField. The authors
observed that cancer cells respond to the TTFields in such a way that they avoid
the field affect. To some extent, this is indirect clinical evidence that supports
the hypothesis that the main reason for the treatment failure is the migration-
proliferation dichotomy, which is completely independent of the field. It should
be noted that TTFields belong to a wide class of therapies that are effective
against the abnormal proliferation of transformed cells. However, as compared
to chemotherapy regimens, the treatment modality is completely different, be-
ing of a physical nature, and accompanied by minimal local side effect and no
systemic side effects [3, 40]. Therefore, therapy efficiency can be improved by
combining chemotherapy with the TTField, as was stated in [40].
The kernel C(r, t) describes the competition between proliferation and degra-
5See http://www.novocure.com/
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dation due to the TTField action. This complicated function is random in space
and time, and the result depends essentially on its sign. When it is negative,
which means that the treatment is sufficient, or is absent, the kernel (21) is no
longer the TTField kernel, and corresponds to proliferation. Since the argument
in the Mittag-Leffler function is positive, this leads to the exponential growth
of the density of cancer cells ∼ exp(Cαt). In this case, the nonlinear mechanism
becomes important in that it restricts the unlimited growth of cell numbers, see
e.g. [36, 37].
First, an analytical attempt to understand the TTField’s influence on glioma
development has been suggested by virtue of the geometrical construction of
both the anomalous cell transport and the inhomogeneous distribution of pro-
liferating cells in the framework of a fractional comb model for the 1D [22] and
the 3D [41] analysis. It has been shown there that the efficiency of the medical
treatment depends essentially on the mass fractal dimension of the cancer in
the outer invasive zone. In the present research, a generalization of these geo-
metrical constructions of the TTField action was suggested. The solution for
the cell density of the developing glioma n(r, t) was obtained for any arbitrary
distribution of proliferating cells. Moreover, the obtained final result in Eq. (29)
corresponds to the compensated cancer solution with C(r, t) = 0. In this case,
any inhomogeneities do not affect subdiffusion of cancer cells that leads to sub-
diffusion of free particles. This result is valid for any arbitrary C(r, t). To some
extent, one can anticipate this property of the intermediate asymptotic result
(29), that all proliferating cells disappear, and correspondingly, the TTField
becomes ineffective. As a result, a clone of migrating cancer cells spreads freely
according to Eq. (29) without the details of the degradation rate of proliferating
cells due to the TTField having an influence. In this case, the TTField plays the
role of an experimental/technological separation mechanism for the surviving
migrating cells only. Probably, this process can be important for understanding
the mechanism of the migration-proliferation dichotomy.
One should recognize that the obtained results correspond to the interme-
diate asymptotic solution according to Eq. (22), when time is restricted from
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above t < Tmax ∼
(
r2max
Kα
) 1
α
=
(
r2max
σ2
) 1
α
τ , where Tmax/τ ≫ 1. Taking Tmax as
the maximum survival time of the order of 103 days [3] and 1/τ ∼ 1(day)−1
as the averaged proliferation rate [8], one obtains Tmax/τ ∼ 103, which cor-
responds to the intermediate asymptotics approximation, performed in Eq.
(22). Therefore, the main conditions for the performed approximations that
are valid for the intermediate asymptotic times t in the outer-invasive region r
are 1 ≫ (τ/t)α ≫ σ2/r2. Taking into account that the outer-invasive region is
of the order of r ∼ 1 cm and σ ∼ 10−3 cm, one obtain that these inequalities
are valid and verify the obtained result.
Finally, it is tempting to find what happens if a patient has a possibility to
survive beyond the time Tmax, when t → ∞. In this case, when s → 0, the
Tauberian theorem [39], applied to Eq. (21), gives R(k, t) ∼ δ(t), which yields
n(r, t → ∞) ≡ 0. Again, one anticipates this result at the infinite time scale,
when all migrating cells have a possibility to be converted into proliferating cells
with further degradation due to the TTField. Therefore, one has to consider a
stationary value problem (for t→∞) with a constant flux of cancer cells from
the boundary of the tumor core, and the result with n(r, t → ∞) ≡ 0 is no
longer valid. Moreover, since the initial value problem of Eq. (11) is described
by the fractional Fokker-Planck equation, the problem of a stationary solution
should be revised carefully. This problem will be the subject of future studies.
I thank E. Yodim for language editing. This work was supported by the
Israel Science Foundation (ISF).
Appendix A. Fractional integro–differentiation
The consideration of a non-Markovian process in the framework of kinetic
equations leads to the study of the so-called fractional Fokker-Planck equation,
where time processes are not local [20]. In this case, time derivations are substi-
tuted by time integration with the power law kernels. One arrives at so-called
fractional integro–differentiation.
A basic introduction to fractional calculus can be found, e.g., in Ref. [35, 42].
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Fractional integration of the order of α is defined by the operator
aI
α
t f(t) =
1
Γ(α)
∫ t
a
f(τ)(t− τ)α−1dτ, (α > 0) , (A. 1)
where Γ(α) is a gamma function. There is no constraint on the limit a. In
our consideration, a = 0 since this is a natural limit for the time. A fractional
derivative is defined as an inverse operator to aI
α
t ≡ Iαt as d
α
dtα = I
−α
t = D
α
t ;
correspondingly Iαt =
d−α
dt−α = D
−α
t . Its explicit form is convolution
Dαt =
1
Γ(−α)
∫ t
0
f(τ)
(t− τ)α+1 dτ . (A. 2)
For arbitrary α > 0, this integral is, in general, divergent. As a regularization
of the divergent integral, the following two alternative definitions for Dαt exist
[34]
RLD
α
(0,t)f(t) ≡ DαRLf(t) = DnIn−αf(t)
1
Γ(n− α)
dn
dtn
∫ t
0
f(τ)dτ
(t− τ)α+1−n ,
(A. 3)
DαCf(t) = I
n−αDnf(t)
1
Γ(n− α)
∫ t
0
f (n)dτ (τ)
(t− τ)α+1−n , (A. 4)
where n − 1 < α < n, n = 1, 2, . . .. Eq. (A. 3) is the Riemann–Liouville
derivative, while Eq. (A. 4) is the fractional derivative in the Caputo form [35,
34]. Performing integration by part in Eq. (A. 3) and then applying Leibniz’s
rule for the derivative of an integral and repeating this procedure n times, we
obtain
DαRLf(t) = D
α
Cf(t) +
n−1∑
k=0
f (k)(0+)
tk−α
Γ(k − α+ 1) . (A. 5)
The Laplace transform can be obtained for Eq. (A. 4). If Lˆ[f(t)] = f˜(s), then
Lˆ [DαCf(t)] = sαf˜(s)−
n−1∑
k=0
f (k)(0+)sα−1−k . (A. 6)
The following fractional derivatives are helpful for the present analysis
DαRL[1] =
t−α
Γ(1− α) , D
α
C [1] = 0 . (A. 7)
We also note that
DαRLt
β =
tβ−αΓ(β + 1)
Γ(β + 1− α) , (A. 8)
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where β > −1 and α > 0. The fractional derivative from an exponential function
can be simply calculated as well by virtue of the Mittag–Leffler function (see
e.g., [35, 33]):
Eγ,δ(z) =
∞∑
k=0
zk
Γ(γk + δ)
. (A. 9)
Therefore, we have the following expression
DαRLe
λt = t−αE1,1−α(λt) . (A. 10)
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